Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter/year-end 2013 financial results conference call for 8:30 a.m. ET on Wednesday, February 12, 2014. The schedules for the press release and conference call are as follows:
|-- Q4 & YE 2013 Press Release:||February 12, 2014 at 7:00 a.m. ET|
|-- Q4 & YE 2013 Conference Call:||February 12, 2014 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||13574983|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13574983.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
About IncyteIncyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts